Find a trial

RAMP 301 / VS-6766-301

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serious Ovarian Cancer

Locations Wesley

Diagnosis Ovarian cancer

SUNRAY-01 / J3M-MC-JZQB

Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Locations Wesley

Diagnosis Lung cancer

SSGJ-709-101

A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors

Locations Wesley

Diagnosis Advanced solid tumours

SUNRAY-02 / J3M-MC-JZQH

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Locations Adelaide, Wesley

Diagnosis Lung cancer

M25-059

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; Carfilzomib

Locations South Brisbane, Wesley

Diagnosis Multiple myeloma

LUNA / CP-MGC026-01

A Study of MGC026 in Participants With Advanced Solid Tumors

Locations Adelaide, Wesley

Diagnosis Advanced solid tumours